Subsequent studies showed that the combination of thiram and HC further inhibited the proliferation and migration of osteosarcoma cells, increased apoptosis and cycle arrest, and further decreased the expression of beta-catenin, c-MYC, Cyclin-D1 and MMP7 compared with HC alone. Here, CTNNB1 is linked to osteosarcoma.